What Is Tumour Suppressor Gene? What You Need to Know

A tumour suppressor gene is a gene that makes proteins which slow or stop cells from growing out of control. When these genes work properly, they act like brakes on cell division. When they are damaged or switched off, cells can divide when they shouldn’t — and that is one route toward cancer.

You inherit two copies of most tumour suppressor genes, one from each parent. In many cases both copies must be lost or damaged before a cell loses that braking control. That “two-hit” idea is one of the most established concepts in cancer biology, and it explains why some inherited cancer risks run in families.

What Is a Tumour Suppressor Gene and How Does It Work?

Tumour suppressor genes code for proteins that regulate the cell cycle, repair damaged DNA, or trigger a cell to self-destruct when something goes wrong. They are the counterweight to oncogenes, which are genes that push cells to grow.

The cell cycle is the sequence a cell follows to copy its DNA and divide. Tumour suppressor proteins act as checkpoints along that sequence. If DNA is damaged, a checkpoint can pause the cycle to allow repair. If the damage is too severe, the cell may be directed to die through a process called apoptosis. This protects the body from passing on faulty genetic instructions.

Two tumour suppressor genes are especially well known. TP53 produces a protein often called the “guardian of the genome.” It responds to DNA damage by halting the cell cycle or triggering apoptosis. RB1 produces a protein that helps hold cells back from dividing until conditions are right.

When a tumour suppressor gene is disabled, that checkpoint fails. The cell can keep dividing with damaged DNA, and errors accumulate. Over time, a series of such changes across multiple genes can lead to cancer. Cancer is generally a disease of many genetic changes, not a single one.

How Do Tumour Suppressor Genes Differ From Oncogenes?

Oncogenes and tumour suppressor genes sit on opposite sides of the same coin. Oncogenes drive growth when they are overactive. Tumour suppressor genes restrain growth, and problems arise when they are underactive.

This creates a key difference in how the two types of genes behave when mutated. A single activating mutation in an oncogene can be enough to push a cell toward growth. For tumour suppressor genes, the situation is usually different: in most cases both copies need to be affected before the brake is fully lost. That is why tumour suppressor gene disorders are often described in terms of “loss of function.”

Some tumour suppressor genes follow what geneticists call a dominant-negative pattern, where one faulty copy can interfere with the working copy. TP53 is a well-known example. This is one reason TP53 mutations have such wide effects across many cancer types.

What Happens When a Tumour Suppressor Gene Is Mutated?

A mutation is a change in the DNA sequence of a gene. In tumour suppressor genes, most cancer-causing mutations reduce or eliminate the gene’s protective function. The cell loses part of its ability to pause, repair, or self-destruct.

These mutations can be inherited or acquired. Inherited mutations are present in every cell of the body from birth. Acquired (somatic) mutations happen during a person’s life, often in a single cell or tissue, and are not passed to children.

Inherited tumour suppressor gene mutations raise cancer risk but do not guarantee cancer. A person born with one faulty copy of a gene such as BRCA1, BRCA2, or RB1 still has one working copy. Cancer risk rises because a second mutation in that same gene, occurring in a single cell over a lifetime, is enough to remove the remaining protection. This is the two-hit concept in practice.

This is why some families show clusters of certain cancers across generations. It also explains why genetic counseling and testing exist for people with strong family histories. A genetic counselor can explain what a result does and does not mean.

Which Cancers Are Linked to Tumour Suppressor Genes?

Nearly every cancer involves changes in tumour suppressor genes, because these genes are central to how cells guard against uncontrolled growth. Some links are especially well documented.

• TP53 — mutations are found in a large share of human cancers, making it the most commonly mutated tumour suppressor gene. Inherited TP53 mutations cause Li-Fraumeni syndrome, which raises risk for several cancer types across a lifetime.
• RB1 — inherited mutations cause retinoblastoma, a cancer of the eye that mostly affects young children. RB1 changes are also seen in some other cancers.
• BRCA1 and BRCA2 — these genes help repair DNA. Inherited mutations raise the risk of breast and ovarian cancer, and are also linked to prostate and pancreatic cancer.
• APC — mutations are linked to familial adenomatous polyposis, a condition that causes many colon polyps and raises colorectal cancer risk.
• PTEN — mutations are associated with Cowden syndrome, which raises risk for breast, thyroid, and endometrial cancers.

Most cancers, however, are not caused by an inherited syndrome. They arise from acquired mutations that build up over years, often influenced by factors such as smoking, radiation exposure, and aging. Age itself matters because more cell divisions over time mean more chances for errors to accumulate.

Can You Test for Tumour Suppressor Gene Mutations?

Genetic testing can identify inherited mutations in known tumour suppressor genes. Testing is typically considered when a person has a strong family history, an early age of cancer onset, or multiple cancers. A genetic counselor or physician is the right starting point.

It is worth being clear about what testing can and cannot do. A positive result means a person carries a mutation that raises risk. It does not mean cancer will definitely develop. A negative result can be reassuring but does not rule out all inherited risk, because testing covers specific genes and specific changes.

Tumour testing is a separate matter. Some cancers are analyzed for mutations in the tumour tissue itself, which can guide treatment decisions. This is different from inherited testing and is managed by the treating oncology team.

Can You Protect Tumour Suppressor Genes?

You cannot change the genes you inherit. You can reduce some of the acquired DNA damage that contributes to mutations over a lifetime. This is not a guarantee against cancer, but the evidence for certain lifestyle factors is solid.

Avoiding tobacco is the single most established step. Smoking is a leading cause of cancer and is linked to DNA damage across many tissues. Limiting alcohol intake, protecting skin from excessive ultraviolet exposure, and maintaining a healthy body weight are also supported by substantial evidence.

Vaccination against cancer-linked infections matters too. Human papillomavirus (HPV) vaccination reduces the risk of cancers caused by HPV, and hepatitis B vaccination reduces liver cancer risk linked to chronic infection. These are well-established public health measures.

No supplement or product has been shown to “repair” or “protect” tumour suppressor genes. Marketing that claims otherwise is not supported by clinical evidence. The honest position is that healthy habits lower some cancer risks, but they do not eliminate them.